EQHQ
Login
EQHQ
Search your stocks
Login
Command Palette
Search for a command to run...
Explore
Watchlists
Chat
Portfolio
Share
Profile
PPLPHARMA
Overview
Shareholding
Peers
Financials
Ratios
Concall
Feed
Documents
PPLPHARMA
Piramal Pharma Ltd.
208.07
(+2.33%)
1W: +2.60%
1M: +5.06%
1Y: +56.53%
Ratios
Cash Conversion Cycle
Latest:
-19.3 days
Return on Equity
Latest:
1.1%
Return on Capital Employed
Latest:
6.6%
Dupont Analysis
Analysis Summary
Metric
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
ROE
14.90%
6.11%
-2.77%
0.24%
1.14%
PAT margin
0.22%
-2.63%
5.73%
13.22%
Asset Turnover
0.65x
0.62x
0.60x
0.63x
0.70x
Leverage
1.92x
1.91x
2.02x
2.03x
1.89x
Efficiency Ratios
Analysis Summary
Metric
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Inventory Days
64.2
65.5
69.1
74.7
77.1
Receivable Days
82.1
83.9
80.7
76.2
77.1
Payable Days
162.7
144.8
149.8
168.7
173.5
Cash Conversion Cycle
-16.4
4.7
0.0
-17.8
-19.3
Return Ratios
Analysis Summary
Metric
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
ROE
14.90%
6.11%
-2.77%
0.24%
1.14%
ROCE
13.06%
7.10%
1.95%
5.07%
6.61%
ROA
7.76%
3.20%
-1.37%
0.12%
0.60%
Explore
Watchlists
Chat
Portfolio